Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2010
06/15/2010US7736637 administering to a cancer patient a soluble tumor necrosis factor related apoptosis inducing ligand (TRAIL) polypeptide, selected from the extracellular domain of human TRAIL or fragment thereof, in the form of an oligomer; treatment of leukemia, melanoma or lymphoma
06/15/2010CA2405050C Production of tcr gamma delta t cells
06/15/2010CA2346362C Novel antibody compositions for preparing enriched mesenchymal progenitor preparations
06/15/2010CA2295940C Epitopes of shigella like toxin and their use as vaccine and in diagnosis
06/15/2010CA2294472C Torsin, torsin genes, and methods of use
06/15/2010CA2286323C Cell culture media for enhanced protein production
06/15/2010CA2284119C Phosphatidyl-3,4,5-triphosphate-dependent protein kinase
06/15/2010CA2250080C Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
06/10/2010WO2010065969A1 Sparc binding scfcs
06/10/2010WO2010065962A2 Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
06/10/2010WO2010065882A1 Dual variable domain immunoglobulins and uses thereof
06/10/2010WO2010065819A1 Method for the treatment of neurodegenerative diseases
06/10/2010WO2010065711A1 An abcb5 epitope and antibodies thereto for the treatment of cancer
06/10/2010WO2010065578A2 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
06/10/2010WO2010065568A2 METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
06/10/2010WO2010065496A1 Anti-ferroportin 1 monoclonal antibodies and uses thereof
06/10/2010WO2010065079A2 Antibodies to il-6 and use thereof
06/10/2010WO2010065078A1 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever
06/10/2010WO2010065077A2 Antagonists of il-6 to prevent or treat thrombosis
06/10/2010WO2010064697A1 Anti-nr10 antibody, and use thereof
06/10/2010WO2010064456A1 Anti-nr10 antibodies and utilization of the same
06/10/2010WO2010064250A1 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
06/10/2010WO2010064208A2 Msp2 antigenic peptides and their use
06/10/2010WO2010064164A1 Bovine viral diarrhea virus with a modified erns protein
06/10/2010WO2010064090A1 Process for the modulation of the antagonistic activity of a monoclonal antibody
06/10/2010WO2010064089A1 Novel anti-cmet antibody
06/10/2010WO2010064012A2 Treatment
06/10/2010WO2010063785A2 Antibody variants having modifications in the constant region
06/10/2010WO2010063783A2 Modulating XRN2
06/10/2010WO2010063746A1 Process for the modulation of the antagonistic activity of a monoclonal antibody
06/10/2010WO2010063711A1 Method for introducing diversity into and assembly of polynucleotide sequences
06/10/2010WO2010063675A1 Fully human influenza m2 specific antibodies
06/10/2010WO2010063138A1 A monoclonal antibody specifically binding to vegf and the hybridoma secreting same and uses thereof
06/10/2010WO2010063113A1 Anti-cobra toxin antibody fragments and method of producing a vhh library
06/10/2010WO2010036976A3 Novel vectors for production of antibodies
06/10/2010WO2010028072A3 Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use
06/10/2010WO2009149486A3 Compounds for treating beta-amyloidoses
06/10/2010WO2009149485A3 Compounds for treating amyloidoses
06/10/2010WO2009136286A3 Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
06/10/2010WO2009056280A8 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals
06/10/2010US20100146659 Plant Virus Designated Tomato Marchitez Virus
06/10/2010US20100146650 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
06/10/2010US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
06/10/2010US20100145031 Methods for producing antibodies from plasma cells
06/10/2010US20100145030 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
06/10/2010US20100145029 Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
06/10/2010US20100145028 Increasing The Production Of Recombinant Antibodies In Mammalian Cells By Site-Directed Mutagenesis
06/10/2010US20100145027 Compositions and Methods for the Diagnosis and Treatment of Tumor
06/10/2010US20100145026 Antibody for ADCC And Inducing Cytokine Production
06/10/2010US20100145025 Recombinant Mouse-Human Chimeric Fab Against Hepatitis B Surface Antigen
06/10/2010US20100145024 Long wavelength engineered fluorescent proteins
06/10/2010US20100145023 Optimized Nucleotide Sequences of VB6-845 For Expression of Recombinant Proteins
06/10/2010US20100145022 Method of Isolating Biomacromolecules Using Low pH and Divalent Cations
06/10/2010US20100145021 Process for enhancing protein recovery yields
06/10/2010US20100144849 METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
06/10/2010US20100144847 Fusion polypeptide suitable as a cytotoxin
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144832 Prostate Cancer-Specific Alternations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144615 Nucleotide sequence encoding a modulator of nf-kb
06/10/2010US20100144589 Methods of predicting cancer lethality using replikin counts
06/10/2010US20100144058 B-lymphocyte stimulator binding polypeptides and methods based thereon
06/10/2010US20100144029 Facilitating Protein Solubility by Use of Peptide Extensions
06/10/2010US20100144027 Placental protein having a regulating action on proteolytic activity and its related gene
06/10/2010US20100143979 Polypeptides having dna polymerase activity
06/10/2010US20100143949 Biomarkers for colorectal cancer
06/10/2010US20100143947 Reagents and methods for use in cancer diagnosis, classification and therapy
06/10/2010US20100143939 Intracellular antibodies
06/10/2010US20100143936 Novel Specific Arabinose Transporter from the Yeast Pichia Stipitis, and Uses Thereof
06/10/2010US20100143935 c-KIT Phosphorylation in Cancer
06/10/2010US20100143934 Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses therefor
06/10/2010US20100143927 Methods and Assays for Measuring p95 and/or p95 in a Sample and Antibodies Specific for p95
06/10/2010US20100143925 Conjugate complexes for analyte detection
06/10/2010US20100143924 Negative correlation between irp-2 and transferrin receptor expression as a diagnostic of alzheimer's disease
06/10/2010US20100143918 Translocation and mutant ros kinase in human non-small cell lung carcinoma
06/10/2010US20100143916 Osteoarthritis biomarkers and uses thereof
06/10/2010US20100143415 Streptococcus Pneumoniae Antigens
06/10/2010US20100143414 Pneumococcal serotypes
06/10/2010US20100143412 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
06/10/2010US20100143407 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
06/10/2010US20100143388 comprise a Fc region comprising complex N-glycoside-linked sugar chains bound to the Fc region; useful for various diseases having high antibody-dependent cell-mediated cytotoxic activity
06/10/2010US20100143387 Multimeric conjugate
06/10/2010US20100143377 Products for prophylaxis and/or treatment of viral diseases and methods of making and using same
06/10/2010US20100143376 Antibodies Specific for Rubella Virus
06/10/2010US20100143374 Diagnostic and therapeutic target for autoimmune diseases and uses thereof
06/10/2010US20100143371 Intrabodies
06/10/2010US20100143368 Human Antibodies That Bind Cd22 And Uses Thereof
06/10/2010US20100143367 Novel anti-cd98 antibody
06/10/2010US20100143365 Methods and materials related to anti-amyloid antibodies
06/10/2010US20100143364 Chimeric Antibodies, Compositions and Methods for Treating Cocaine-Related Disorders
06/10/2010US20100143363 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
06/10/2010US20100143362 LINGO binding molecules and Pharmaceutical Use Thereof
06/10/2010US20100143360 Human vascular endothelial growth factor 2
06/10/2010US20100143359 Expression of foxp3 by cancer cells
06/10/2010US20100143356 Therapeutic and diagnostic anti-hsp70 antibodies
06/10/2010US20100143355 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
06/10/2010US20100143353 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME
06/10/2010US20100143352 Combination therapy for b cell disorders
06/10/2010US20100143349 Humanized anti-rage antibody
06/10/2010US20100143345 Epha2 agonistic monoclonal antibodies and methods of use thereof
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 1494